who otherwise exhibit a combination of factors that may result in slower metabolism of olanzapine (e.g., nonsmoking female patients ≥65 yearsof age), or who may be more pharmacodynamically sensitive to olanzapine [seeWARNINGS AND PRECAUTIONS,DRUG INTERACTIONS, ...
Dose group differences have been observed for weight, fasting triglycerides and prolactin elevation for ZYPREXA RELPREVV [seeWARNINGS AND PRECAUTIONS]. A dose group difference for oral olanzapine has been observed for fatigue, dizziness, weight gain and prolactin elevation. In a single 8-week randomize...